AA and DHA are decreased in paediatric AD/HD and inattention is ameliorated by increased plasma DHA

AA and DHA are decreased in paediatric AD/HD and inattention is ameliorated by increased plasma DHA

The purpose of this study was to assess long chain polyunsaturated fatty acid (LCPUFA) status in relation to socio-behavioral outcomes in children with Attention Deficit/Hyperactivity Disorder (AD/HD). In a case-control design, plasma phospholipid fatty acid content was assessed in children aged 5–1...

Full description

Bibliographic Details
Main Authors:	John J. Miklavcic, Ellen Ivity, Ian M. MacDonald, Liana Urichuk, Vera C. Mazurak, Christina Rinaldi, Michael T. Clandinin
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Human Nutrition & Metabolism
Subjects:	Polyunsaturated fatty acid Nutrition Fatty acid desaturase Essential fatty acid Arachidonic acid Docosahexaenoic acid
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666149722000469

Similar Items

The role of docosahexaenoic acid in neuronal development and the importance of DHA supplementation during pregnancy
by: Aleksandra Karmańska, et al.
Published: (2023-10-01)

Complete assessment of whole-body n-3 and n-6 PUFA synthesis-secretion kinetics and DHA turnover in a rodent model
by: Adam H. Metherel, et al.
Published: (2018-02-01)

fabH deletion increases DHA production in Escherichia coli expressing Pfa genes
by: Laura Giner-Robles, et al.
Published: (2018-06-01)

Controlled formation of mono- and dihydroxy-resolvins from EPA and DHA using soybean 15-lipoxygenase[S]
by: Eleanor P. Dobson, et al.
Published: (2013-05-01)

Maternal and Neonatal Polyunsaturated Fatty Acid Intake and Risk of Neurodevelopmental Impairment in Premature Infants
by: Rory J. Heath, et al.
Published: (2022-01-01)

DHA and ARA and development of brain and eyes ‐ Scientific substantiation of a health claim related to Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) and support of the neural development of the brain and eyes pursuant to Article 14 of Regulation (EC) No 1924/2006
by: European Food Safety Authority (EFSA)
Published: (2008-09-01)

Research Progress of Mitochondrial-Mediated Docosahexaenoic Acid (DHA) Antioxidation
by: Xiaoting SUN, et al.
Published: (2022-05-01)

Evaluation of Plasma AA/DHA+EPA Ratio in Obese Romanian Children
by: Huțanu Adina, et al.
Published: (2021-04-01)

Polyunsaturated Fatty Acid Intake during Complementary Feeding and Neurodevelopmental Outcome in Very Low Birth Weight Infants
by: Melanie Gsoellpointner, et al.
Published: (2023-07-01)

A More Comprehensive Approach to the Neuroprotective Potential of Long-Chain Polyunsaturated Fatty Acids in Preterm Infants Is Needed—Should We Consider Maternal Diet and the n-6:n-3 Fatty Acid Ratio?
by: Susanna Klevebro, et al.
Published: (2020-01-01)

Identification of a fatty acid Δ6-desaturase deficiency in human skin fibroblasts
by: Deborah E. Williard, et al.
Published: (2001-04-01)

Disruption of FADS2 gene in mice impairs male reproduction and causes dermal and intestinal ulceration
by: Chad K. Stroud, et al.
Published: (2009-09-01)

A procedure for preparing oxazolines of highly unsaturated fatty acids to determine double bond positions by mass spectrometry
by: Dmitry V. Kuklev, et al.
Published: (2003-05-01)

Perinatal Polyunsaturated Fatty Acid Status and Obesity Risk
by: Hans Demmelmair, et al.
Published: (2021-10-01)

Role of ω-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma
by: Yvonne Denkins, et al.
Published: (2005-06-01)

Competition between 24:5n-3 and ALA for Δ6 desaturase may limit the accumulation of DHA in HepG2 cell membranes
by: Roxanne Portolesi, et al.
Published: (2007-07-01)

Efalex® and brain development and function ‐ Scientific substantiation of a health claim related to Efalex® and brain development and function pursuant to Article14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies
by: European Food Safety Authority (EFSA)
Published: (2008-12-01)

Efalex® and concentration ‐ Scientific substantiation of a health claim related to Efalex® and concentration pursuant to Article14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies
by: European Food Safety Authority (EFSA)
Published: (2008-12-01)

Efalex® and eye development and function ‐ Scientific substantiation of a health claim related to Efalex® and eye development and function pursuant to Article14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies
by: European Food Safety Authority (EFSA)
Published: (2008-12-01)

Efalex® and coordination ‐ Scientific substantiation of a health claim related to Efalex® and coordination pursuant to Article14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies
by: European Food Safety Authority (EFSA)
Published: (2008-12-01)

Abnormal n-6 fatty acid metabolism in cystic fibrosis is caused by activation of AMP-activated protein kinase
by: Obi C. Umunakwe, et al.
Published: (2014-07-01)

EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4
by: Julie A. Eclov, et al.
Published: (2015-12-01)

Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line
by: Li-Hsuan Huang, et al.
Published: (2017-12-01)

Self-Reported DHA Supplementation during Pregnancy and Its Association with Obesity or Gestational Diabetes in Relation to DHA Concentration in Cord and Maternal Plasma: Results from NELA, a Prospective Mother-Offspring Cohort
by: Antonio Gázquez, et al.
Published: (2021-03-01)

A Diet With Docosahexaenoic and Arachidonic Acids as the Sole Source of Polyunsaturated Fatty Acids Is Sufficient to Support Visual, Cognitive, Motor, and Social Development in Mice
by: Sarah J. Carlson, et al.
Published: (2019-02-01)

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults
by: Toshiaki Sueyasu, et al.
Published: (2023-06-01)

Les rôles physiologiques majeurs exercés par les acides gras polyinsaturés (AGPI)
by: Guesnet Philippe, et al.
Published: (2005-09-01)

Value of long-chain polyunsaturated fatty acids for infants’ health and development
by: Д. О. Добрянський, et al.
Published: (2019-06-01)

Athletes Can Benefit from Increased Intake of EPA and DHA—Evaluating the Evidence
by: Maja Tomczyk, et al.
Published: (2023-11-01)

A complete enzymatic capacity for biosynthesis of docosahexaenoic acid (DHA, 22 : 6n–3) exists in the marine Harpacticoida copepod Tigriopus californicus
by: Naoki Kabeya, et al.
Published: (2021-04-01)

Whole body distribution of deuterated linoleic and α-linolenic acids and their metabolites in the rat
by: Yu Hong Lin, et al.
Published: (2007-12-01)

Secular Decreasing Trend in Plasma Eicosapentaenoic and Docosahexaenoic Acids among Patients with Acute Coronary Syndrome from 2011 to 2019: A Single Center Descriptive Study
by: Tomoaki Okada, et al.
Published: (2021-01-01)

Efficient Enrichment of Retinal DHA with Dietary Lysophosphatidylcholine-DHA: Potential Application for Retinopathies
by: Dhavamani Sugasini, et al.
Published: (2020-10-01)

Efalex® and learning ability ‐ Scientific substantiation of a health claim related to Efalex® and learning ability pursuant to Article14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies
by: European Food Safety Authority (EFSA)
Published: (2008-12-01)

Australian thraustochytrids: Potential production of dietary long-chain omega-3 oils using crude glycerol
by: Kim Jye Lee Chang, et al.
Published: (2015-12-01)

Comparative Transcriptomic Analysis Uncovers Genes Responsible for the DHA Enhancement in the Mutant <i>Aurantiochytrium</i> sp.
by: Liangxu Liu, et al.
Published: (2020-04-01)

DHA attenuates postprandial hyperlipidemia via activating PPARα in intestinal epithelial cells[S]
by: Rino Kimura, et al.
Published: (2013-12-01)

Harnessing the Lipogenic Potential of Δ6-Desaturase for Simultaneous Hyperaccumulation of Lipids and Polyunsaturated Fatty Acids in Nannochloropsis oceanica
by: Fan Yang, et al.
Published: (2019-11-01)

Requirement of PPARα in maintaining phospholipid and triacylglycerol homeostasis during energy deprivation
by: Susanna S.T. Lee, et al.
Published: (2004-11-01)

Le DHA dans la neurotransmission
by: Lavialle Monique, et al.
Published: (2007-01-01)